A Keystone Gut Bacterium Christensenella minuta—A Potential Biotherapeutic Agent for Obesity and Associated Metabolic Diseases

Keyphrases

• Obesity 100%
• Metabolic Disease 100%
• Microbiome 100%
• Therapeutic Proteins 100%
• Gut Bacteria 100%
• Host Metabolism 100%
• Christensenella 100%
• Firmicutes 50%
• Inflammatory Bowel Disease 50%
• Complex Interactions 50%
• Oral Administration 50%
• Type 2 Diabetes Mellitus (T2DM) 50%
• Healthy Individuals 50%
• Relative Abundance 50%
• Mechanism of Action 50%
• Fecal Microbiota Transplantation 50%
• Metabolic Health 50%
• Mutual Interaction 50%
• Gut Dysbiosis 50%
• Potential Health Benefits 50%
• Low BMI 50%
• Christensenella Minuta 50%
• Biotherapy 50%
• Host Phenotype 50%
• BMI Index 50%
• Commensal Bacteria 50%
• Next-generation Probiotics 50%
• Human Stool 50%

Medicine and Dentistry

• Water-Electrolyte Imbalance 100%
• Gut 100%
• Microbiome 100%
• Body Mass Index 50%
• Oral Drug Administration 50%
• Maturity Onset Diabetes of the Young 50%
• Fecal Microbiota Transplantation 50%
• Gut Microbiota 50%
• Probiotic Agent 50%
• Dysbiosis 50%
• Firmicutes 50%
• Biological Therapy 50%
• Inflammatory Bowel Disease 50%

Immunology and Microbiology

• Intestine Flora 100%
• Microbiome 100%
• Firmicutes 50%
• Normal Human 50%
• Phylum 50%
• Feces microflora 50%
• Probiotic 50%
• Inflammatory Bowel Disease 50%